JP2020535193A5 - - Google Patents

Download PDF

Info

Publication number
JP2020535193A5
JP2020535193A5 JP2020517938A JP2020517938A JP2020535193A5 JP 2020535193 A5 JP2020535193 A5 JP 2020535193A5 JP 2020517938 A JP2020517938 A JP 2020517938A JP 2020517938 A JP2020517938 A JP 2020517938A JP 2020535193 A5 JP2020535193 A5 JP 2020535193A5
Authority
JP
Japan
Prior art keywords
formula
linagliptin
linagliptin intermediate
reaction mass
intermediate represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020517938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020535193A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/057484 external-priority patent/WO2019064214A1/en
Publication of JP2020535193A publication Critical patent/JP2020535193A/ja
Publication of JP2020535193A5 publication Critical patent/JP2020535193A5/ja
Pending legal-status Critical Current

Links

JP2020517938A 2017-09-27 2018-09-27 結晶のリナグリプチン中間体およびリナグリプチンの調製のためのプロセス Pending JP2020535193A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201741034292 2017-09-27
IN201741034292 2017-09-27
PCT/IB2018/057484 WO2019064214A1 (en) 2017-09-27 2018-09-27 INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN

Publications (2)

Publication Number Publication Date
JP2020535193A JP2020535193A (ja) 2020-12-03
JP2020535193A5 true JP2020535193A5 (cg-RX-API-DMAC7.html) 2021-10-28

Family

ID=65903063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020517938A Pending JP2020535193A (ja) 2017-09-27 2018-09-27 結晶のリナグリプチン中間体およびリナグリプチンの調製のためのプロセス

Country Status (10)

Country Link
US (1) US11040974B2 (cg-RX-API-DMAC7.html)
JP (1) JP2020535193A (cg-RX-API-DMAC7.html)
KR (1) KR20200092946A (cg-RX-API-DMAC7.html)
CN (1) CN111511743A (cg-RX-API-DMAC7.html)
AU (1) AU2018343236A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020005964A2 (cg-RX-API-DMAC7.html)
CA (1) CA3076980A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020004050A (cg-RX-API-DMAC7.html)
RU (1) RU2020114890A (cg-RX-API-DMAC7.html)
WO (1) WO2019064214A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110684026A (zh) * 2019-10-24 2020-01-14 扬子江药业集团上海海尼药业有限公司 一种利格列汀的工业化制备方法
CN110872292B (zh) * 2019-11-30 2022-01-25 江苏君若药业有限公司 一条合成糖尿病药物利拉利汀的路线
EP4349837A1 (en) 2022-10-05 2024-04-10 Zaklady Farmaceutyczne "Polpharma" S.A. A pharmaceutical intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
BRPI0711558A2 (pt) 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
IN2013MU02055A (cg-RX-API-DMAC7.html) * 2013-06-18 2015-07-03 Cadila Healthcare Ltd
WO2015011609A1 (en) * 2013-07-23 2015-01-29 Ranbaxy Laboratories Limited Process for the preparation of linagliptin and an intermediate thereof

Similar Documents

Publication Publication Date Title
JP6872500B2 (ja) ブリバラセタムを製造する方法
KR102292928B1 (ko) 축합 헤테로사이클릭 화합물의 제조 방법
JP2021530565A5 (cg-RX-API-DMAC7.html)
CN110337434B (zh) 制备2-氰基咪唑化合物的方法
JP2022511800A5 (cg-RX-API-DMAC7.html)
JP2014507414A5 (cg-RX-API-DMAC7.html)
JP2006137778A5 (cg-RX-API-DMAC7.html)
WO2010125414A1 (en) Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine
US10377710B2 (en) Process for the preparation of considerably pure Silodosin
CN105646368A (zh) 一种2,4-二氯-5-甲氧基嘧啶的制备方法
JP2016510767A5 (cg-RX-API-DMAC7.html)
RU2020114890A (ru) Кристаллическое промежуточное соединение, используемое для получения линаглиптина, и способ получения линаглиптина
JP2023530786A5 (cg-RX-API-DMAC7.html)
JP2013541589A5 (cg-RX-API-DMAC7.html)
JP5984988B2 (ja) (+)および(−)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの合成のための方法
CN103896858B (zh) 胞嘧啶的制备工艺
CN102757390B (zh) 一种制备2-甲氧基-4-肼基-5-氟嘧啶的方法
WO2016042441A1 (en) A novel process for the preparation of considerably pure silodosin
WO2014206254A1 (zh) 一种4-苄基-1-苯乙基哌嗪-2,6-二酮的制备方法、中间体及其制备方法
CN103450092B (zh) 一类甲硝唑‑磺胺衍生物的合成方法
JP2018528981A (ja) プラジカンテルおよびその前駆体の製造方法
JP2020083892A5 (cg-RX-API-DMAC7.html)
TW200920740A (en) Process for preparing 4-aminobut-2-enolides
CN104016967A (zh) 一种泊利度胺的合成方法
CN104876911A (zh) 一种简易的方法合成德拉沙星